Peter H. O'Donnell to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications Peter H. O'Donnell has written about Clinical Trials, Phase I as Topic.
Connection Strength
0.054
-
Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant. Leuk Lymphoma. 2014 Dec; 55(12):2866-73.
Score: 0.029
-
Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: a retrospective analysis of pooled, prospective phase 2 trials. Eur Urol. 2013 Apr; 63(4):717-23.
Score: 0.026